Kubota Pharmaceutical Holdings Co., Ltd. Sustainability Profile
Kubota Pharmaceutical Holdings Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in Japan (JP) and operates extensively across Asia and beyond. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative therapies, particularly in the fields of oncology and rare diseases. Kubota Pharmaceutical is renowned for its unique approach to drug development, focusing on precision medicine and advanced biopharmaceuticals. Its core products aim to address unmet medical needs, setting the company apart in a competitive market. With a commitment to research and development, Kubota has achieved significant milestones, including strategic partnerships and successful clinical trials, reinforcing its position as a forward-thinking entity in the pharmaceutical landscape.
DitchCarbon Score
How does Kubota Pharmaceutical Holdings Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kubota Pharmaceutical Holdings Co., Ltd.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kubota Pharmaceutical Holdings Co., Ltd.'s reported carbon emissions
Kubota Pharmaceutical Holdings Co., Ltd., headquartered in Japan, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Kubota Pharmaceutical may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information at this time. As a result, the company's climate initiatives and strategies remain unclear within the context of industry standards for emissions reporting and climate action.
How Carbon Intensive is Kubota Pharmaceutical Holdings Co., Ltd.'s Industry?
How Carbon Intensive is Kubota Pharmaceutical Holdings Co., Ltd.'s Location?
Kubota Pharmaceutical Holdings Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kubota Pharmaceutical Holdings Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
